|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Product revenues | ||
| Cost of sales | ||
| Gross profit | ||
| Operating expenses: | ||
| Selling, general and administrative | ||
| Research and development | ||
| Total operating expenses | ||
| Loss from operations | ||
| Change in fair value of warrant liability | ||
| Loss before income tax benefit | ||
| Income tax benefit | ||
| Net Loss | ||
| Loss Per Common Share | ||
| Basic | ||
| Diluted | ||
| Weighted-average common shares outstanding: | ||
| Basic | ||
| Diluted |
Loading...
